1. Home
  2. IE vs PCRX Comparison

IE vs PCRX Comparison

Compare IE & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IE
  • PCRX
  • Stock Information
  • Founded
  • IE 2020
  • PCRX 2006
  • Country
  • IE United States
  • PCRX United States
  • Employees
  • IE N/A
  • PCRX N/A
  • Industry
  • IE Metal Mining
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IE Basic Materials
  • PCRX Health Care
  • Exchange
  • IE Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • IE 1.0B
  • PCRX 1.2B
  • IPO Year
  • IE 2022
  • PCRX 2011
  • Fundamental
  • Price
  • IE $11.61
  • PCRX $22.55
  • Analyst Decision
  • IE Strong Buy
  • PCRX Buy
  • Analyst Count
  • IE 3
  • PCRX 8
  • Target Price
  • IE $12.67
  • PCRX $28.38
  • AVG Volume (30 Days)
  • IE 1.6M
  • PCRX 565.4K
  • Earning Date
  • IE 08-06-2025
  • PCRX 08-05-2025
  • Dividend Yield
  • IE N/A
  • PCRX N/A
  • EPS Growth
  • IE N/A
  • PCRX N/A
  • EPS
  • IE N/A
  • PCRX N/A
  • Revenue
  • IE $3,276,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • IE $64.50
  • PCRX $7.92
  • Revenue Next Year
  • IE $0.73
  • PCRX $11.02
  • P/E Ratio
  • IE N/A
  • PCRX N/A
  • Revenue Growth
  • IE N/A
  • PCRX 3.08
  • 52 Week Low
  • IE $4.50
  • PCRX $11.16
  • 52 Week High
  • IE $12.05
  • PCRX $27.64
  • Technical
  • Relative Strength Index (RSI)
  • IE 69.60
  • PCRX 43.85
  • Support Level
  • IE $11.00
  • PCRX $21.26
  • Resistance Level
  • IE $12.03
  • PCRX $22.95
  • Average True Range (ATR)
  • IE 0.63
  • PCRX 0.83
  • MACD
  • IE 0.06
  • PCRX 0.01
  • Stochastic Oscillator
  • IE 85.28
  • PCRX 48.68

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: